drugset / Trial / NCT06742840
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-2129 in healthy subjects.
Timeline
- Start
- 2024-12-30
- Primary completion
- 2025-07-02
- Completion
- 2025-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-2129 | Unknown | — | — |
Indications
No indication recorded.